Home Business & Finance Teva CEO on Drug Pipeline, Direct Listing on NYSE
Business & Finance

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Key Points

Jul 29th, 2026 Teva CEO on Drug Pipeline, Direct Listing on NYSE Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.

Jul 29th, 2026 Teva CEO on Drug Pipeline, Direct Listing on NYSE Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.
Teva (ORG) Drug Pipeline (ORG) NYSE Teva Pharmaceuticals (ORG) Richard Francis (PERSON) Bloomberg (ORG) Romaine Bostick (PERSON) Q2 (ORG) Medicare (ORG) NYSE (ORG)
Originally published by Bloomberg Markets Read original →